Browse All

Current Filters

CLEAR FILTER x

TITLE

Session Name:

KHN702, a Novel Selective hNav1.8 Inhibitor for Pain Therapy

Author:Liu, Ting   Huang, Hong   Mu, Ke   Yu, yongguo   Cai, Zuhuan   Bai, Yu   Ke, Xiao   

Session Name:S38: Pain  

Topic:Pain  

Program Number:S38.002  

Author Institution:Chengdu Kanghong Pharmaceutical Group Co., Ltd, Chengdu, China, People's Republic of  Chengdu Kanghong Pharmaceutical Group Co., Ltd, Chengdu Sichuan , China, People's Republic of  Chengdu Kanghong Pharmaceutical Group Co., Ltd, sichuan chengdu, China, People's Republic of  

Basimglurant, a Novel mGluR5 Negative Allosteric Modulator, is Analgesic in Animal Models of Neuropathic and Chronic Pain

Author:Wettstein, Joseph   Roeloffs, Rosemarie   Garibaldi, George   Bernard, Delphine   Knappertz, Volker   

Session Name:S38: Pain  

Topic:Pain  

Program Number:S38.003  

Author Institution:Noema Pharma, Switzerland  Noema Pharma, MA  

Opioid Signaling in DRG Neurons- New Players in the Side Effects of Chronic Opioid Use

Author:Goguadze, Nino   Wu, Hsiang-En   Su, Tsung-Ping   

Session Name:S38: Pain  

Topic:Pain  

Program Number:S38.004  

Author Institution:Hackensack Meridian Neuroscience Institute at JFK University Medical Center, NJ  Cellular Pathobiology Section, Integrative Neuroscience Research Branch, IRP, NIDA, NIH, MD  

Additional Efficacy Data Support Selection of Pilavapadin 10mg for Phase Three Development in DPNP: Results From PROGRESS

Author:Gopinathan, Suma   Granowitz, Craig   Hardin, Marquette   Banks, Phillip   Pierce, Phillip   Girard, Manon   

Session Name:S38: Pain  

Topic:Pain  

Program Number:S38.005  

Author Institution:Lexicon Pharmaceuticals, Bridgewater, NJ